These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 20947151)

  • 21. A contemporary analysis of the ability of preoperative serum CA-125 to predict primary cytoreductive outcome in patients with advanced ovarian, tubal and peritoneal carcinoma.
    Chi DS; Zivanovic O; Palayekar MJ; Eisenhauer EL; Abu-Rustum NR; Sonoda Y; Levine DA; Leitao MM; Brown CL; Barakat RR
    Gynecol Oncol; 2009 Jan; 112(1):6-10. PubMed ID: 19100916
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Influence of surgical quality in the treatment of cancer of the ovary and fallopian tubes].
    Uyttenbroeck F
    Chirurgie; 1994-1995; 120(5):250-2; discussion 253. PubMed ID: 7743843
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Negative laparoscopy is highly predictive of negative second-look laparotomy following chemotherapy for ovarian, tubal, and primary peritoneal carcinoma.
    Littell RD; Hallonquist H; Matulonis U; Seiden MV; Berkowitz RS; Duska LR
    Gynecol Oncol; 2006 Nov; 103(2):570-4. PubMed ID: 16769104
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Robotic approach for ovarian cancer: perioperative and survival results and comparison with laparoscopy and laparotomy.
    Magrina JF; Zanagnolo V; Noble BN; Kho RM; Magtibay P
    Gynecol Oncol; 2011 Apr; 121(1):100-5. PubMed ID: 21194736
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Wilms tumor gene immunoreactivity in primary serous carcinomas of the fallopian tube, ovary, endometrium, and peritoneum.
    Hashi A; Yuminamochi T; Murata S; Iwamoto H; Honda T; Hoshi K
    Int J Gynecol Pathol; 2003 Oct; 22(4):374-7. PubMed ID: 14501819
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The safety and efficacy of laparoscopic surgical staging and debulking of apparent advanced stage ovarian, fallopian tube, and primary peritoneal cancers.
    Nezhat FR; DeNoble SM; Liu CS; Cho JE; Brown DN; Chuang L; Gretz H; Saharia P
    JSLS; 2010; 14(2):155-68. PubMed ID: 20932362
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessment of intraoperative tube thoracostomy after diaphragmatic resection as part of debulking surgery for primary advanced-stage Müllerian cancer.
    Kato K; Tate S; Nishikimi K; Shozu M
    Gynecol Oncol; 2013 Oct; 131(1):32-5. PubMed ID: 23891788
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Surgical manual of the Korean Gynecologic Oncology Group: ovarian, tubal, and peritoneal cancers.
    Jeon S; Lee SJ; Lim MC; Song T; Bae J; Kim K; Lee JY; Kim SW; Chang SJ; Lee JM
    J Gynecol Oncol; 2017 Jan; 28(1):e6. PubMed ID: 27670260
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cytoreductive surgery for advanced ovarian cancer.
    Pölcher M; Zivanovic O; Chi DS
    Womens Health (Lond); 2014 Mar; 10(2):179-90. PubMed ID: 24601809
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of perioperative venous thromboembolism on survival in ovarian, primary peritoneal, and fallopian tube cancer.
    Black D; Iasonos A; Ahmed H; Chi DS; Barakat RR; Abu-Rustum NR
    Gynecol Oncol; 2007 Oct; 107(1):66-70. PubMed ID: 17614125
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transfusion utilization during adnexal or peritoneal cancer surgery: effects on symptomatic venous thromboembolism and survival.
    Abu-Rustum NR; Richard S; Wilton A; Lev G; Sonoda Y; Hensley ML; Gemignani M; Barakat RR; Chi DS
    Gynecol Oncol; 2005 Nov; 99(2):320-6. PubMed ID: 16061278
    [TBL] [Abstract][Full Text] [Related]  

  • 32. What is the role of reassessment laparoscopy in the management of gynecologic cancers in 1995?
    Casey AC; Farias-Eisner R; Pisani AL; Cirisano FD; Kim YB; Muderspach L; Futoran R; Leuchter RS; Lagasse LD; Karlan BY
    Gynecol Oncol; 1996 Mar; 60(3):454-61. PubMed ID: 8774657
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Safe dissection of high paraaortic lymph nodes superior to the renal vein in ovarian, primary peritoneal, or fallopian tube cancer by the "Komiyama's maneuver", a modification of Kocher's maneuver.
    Komiyama S; Manrai M; Takahashi R; Takeya C
    Gynecol Oncol; 2017 May; 145(2):407-408. PubMed ID: 28237617
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The safety and efficacy of laparoscopic surgical staging of apparent stage I ovarian and fallopian tube cancers.
    Chi DS; Abu-Rustum NR; Sonoda Y; Ivy J; Rhee E; Moore K; Levine DA; Barakat RR
    Am J Obstet Gynecol; 2005 May; 192(5):1614-9. PubMed ID: 15902166
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characteristics and management of diaphragm involvement in patients with primary advanced-stage ovarian, fallopian tube, or peritoneal cancer.
    Einenkel J; Ott R; Handzel R; Braumann UD; Horn LC
    Int J Gynecol Cancer; 2009 Oct; 19(7):1288-97. PubMed ID: 19823067
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prospective study of the correlation between postoperative computed tomography scan and primary surgeon assessment in patients with advanced ovarian, tubal, and peritoneal carcinoma reported to have undergone primary surgical cytoreduction to residual disease 1 cm or less.
    Chi DS; Ramirez PT; Teitcher JB; Mironov S; Sarasohn DM; Iyer RB; Eisenhauer EL; Abu-Rustum NR; Sonoda Y; Levine DA; Brown CL; Aghajanian C; Gershenson DM; Hoskins WJ; Hricak H; Barakat RR
    J Clin Oncol; 2007 Nov; 25(31):4946-51. PubMed ID: 17971592
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A phase II evaluation of mifepristone in the treatment of recurrent or persistent epithelial ovarian, fallopian or primary peritoneal cancer: a gynecologic oncology group study.
    Rocereto TF; Brady WE; Shahin MS; Hoffman JS; Small L; Rotmensch J; Mannel RS
    Gynecol Oncol; 2010 Mar; 116(3):332-4. PubMed ID: 19922989
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Incidence of and risk factors for postoperative ileus in women undergoing primary staging and debulking for epithelial ovarian carcinoma.
    Bakkum-Gamez JN; Langstraat CL; Martin JR; Lemens MA; Weaver AL; Allensworth S; Dowdy SC; Cliby WA; Gostout BS; Podratz KC
    Gynecol Oncol; 2012 Jun; 125(3):614-20. PubMed ID: 22370599
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phase III trial of upfront debulking surgery versus neoadjuvant chemotherapy for stage III/IV ovarian, tubal and peritoneal cancers: Japan Clinical Oncology Group Study JCOG0602.
    Onda T; Matsumoto K; Shibata T; Sato A; Fukuda H; Konishi I; Kamura T; Yoshikawa H;
    Jpn J Clin Oncol; 2008 Jan; 38(1):74-7. PubMed ID: 18258715
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Incidence and management of pancreatic leaks after splenectomy with distal pancreatectomy performed during primary cytoreductive surgery for advanced ovarian, peritoneal and fallopian tube cancer.
    Kehoe SM; Eisenhauer EL; Abu-Rustum NR; Sonoda Y; D'Angelica M; Jarnagin WR; Barakat RR; Chi DS
    Gynecol Oncol; 2009 Mar; 112(3):496-500. PubMed ID: 19091388
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.